By inhibiting the NLRP3 inflammasome in a murine model, Cheng et al. achieved improved exercise capacity, left ventricular diastolic function, and reduced glucose intolerance, lowering the levels of pro-inflammatory cytokines and attenuating adverse myocardial remodeling [40]. Here, NLRP3 is linked to Glucose intolerance.